Byulleten Sibirskoy Meditsiny, published by the Siberian State Medical University, is a pivotal open-access journal in the field of Molecular Medicine, with its current edition indexed under the ISSN 1682-0363. Since its transition to open access in 2013, the journal aims to disseminate high-quality research and advancements in biomedical sciences, particularly focusing on molecular mechanisms and therapeutic interventions. Despite its relatively recent recognition in Molecular Medicine, where it ranks in the 6th percentile, the journal is dedicated to fostering knowledge exchange and collaboration among researchers, professionals, and students alike. With a modest impact factor and quarterly publication, Byulleten Sibirskoy Meditsiny is positioned to serve as a valuable resource for those engaged in the intricate realms of molecular biology, biochemistry, and general medicine, contributing to the broader scientific discourse in the Russian Federation and beyond.

GeoHealth is a premier open-access journal published by the American Geophysical Union, focusing on the intersection of environmental and health sciences. Launched in 2017, the journal has rapidly established itself with an impressive Q1 ranking in multiple categories, including Epidemiology, Global and Planetary Change, and Public Health, reflecting its commitment to high-quality research and impactful scholarship. Covering a broad spectrum of topics, GeoHealth provides a platform for scientific discussions on key issues such as health, environmental sustainability, pollution, and governance. With an accessible model, researchers and practitioners can freely share and access vital findings, significantly contributing to advancements in public health and environmental management. Exploring critical dimensions of health in relation to environmental changes, GeoHealth is essential reading for those seeking to understand and address contemporary challenges in health and environmental sectors.

Asian Biomedicine, published by WALTER DE GRUYTER GMBH, serves as a crucial platform for disseminating pioneering research in the field of biomedical sciences. Established in 2008, this journal has carved its niche in the landscape of academic publishing, concentrating on a diverse array of topics within biochemistry, genetics, and molecular biology, as well as medicine. Though it currently holds a Q4 ranking in its category, it is dedicated to fostering academic discussions and advancing knowledge among researchers, professionals, and students alike. While the journal features a variety of access options, it is committed to ensuring that its content remains relevant and impactful, with an emphasis on the latest developments and research trends. The editorial board encourages submissions that address pressing biomedical issues, thus empowering contributors to engage meaningfully with the scientific community. With a broad international scope and a focus on quality, Asian Biomedicine is poised to play an increasingly important role in the advancement of biomedical research in Asia and beyond.

IJID Regions is a pioneering open access journal published by Elsevier, focusing on the critical fields of epidemiology, infectious diseases, and public health. Established in 2021, the journal aims to provide a platform for disseminating high-quality, innovative research that addresses pressing health issues and informs evidence-based practices in communities around the globe. With its impact factors reflecting a Tier Q2 and Q3 ranking in various medical subcategories on the Scopus platform, IJID Regions is positioned as a valuable resource for researchers, health professionals, and policy-makers striving to enhance public health outcomes. This journal not only champions open access since its inception, promoting the free flow of information, but also welcomes contributions that shed light on contemporary challenges in environmental and occupational health. Its commitment to fostering dialogue and collaboration in the health sciences is paramount, making it an essential read for those engaged in advancing public health knowledge and initiatives.

Environmental Health Perspectives (EHP) is a premier open-access journal published by the U.S. Department of Health and Human Services, Public Health Science, dedicated to publishing rigorous and impactful research in the field of environmental health. Since its inception in 1972, EHP has become a leading platform for disseminating knowledge on the interactions between the environment and human health, making significant contributions to the fields of toxicology and public health. With an impressive impact factor and a Q1 ranking in both Health, Toxicology and Mutagenesis and Public Health, Environmental and Occupational Health categories, EHP ranks among the top journals globally, reflecting its high citation and visibility within the academic community. Researchers, professionals, and students alike will find a wealth of vital information within its pages, as EHP covers a wide array of topics related to environmental exposures, health outcomes, and policy implications. Furthermore, EHP engages with a global audience through its commitment to open access, ensuring that critical research is available to all, enhancing the collective understanding of environmental health issues since 1972.

Nigerian Journal of Basic and Clinical Sciences, published by Wolters Kluwer Medknow Publications, serves as a vital platform for disseminating research in the fields of health policy, medicine, and public health, specifically addressing the unique challenges and advancements within these areas in Nigeria and beyond. With an impressive array of contributions, this journal, recognized under the ISSN 0331-8540 and E-ISSN 2320-477X, aims to foster scholarly communication and offer innovative insights particularly pertinent to developing regions. Despite being positioned in the Q4 category for various medical fields in 2023 and receiving low Scopus ranks, the journal stands out as a valuable resource for aspiring researchers, healthcare professionals, and students aiming to explore basic and clinical sciences. While it follows a traditional publication model, it remains an indispensable source for cutting-edge research and case studies that can significantly impact health outcomes. The journal has been consistently publishing since its inception in 2012 and continues to play an important role in advancing the academic discourse within its scope.

FASEB BioAdvances, published by WILEY, is an esteemed open-access journal dedicated to advancing the fields of biochemistry, molecular biology, and physiology. Since its inception in 2019, the journal has rapidly established a significant presence within the academic community, boasting an impressive impact factor reflective of its Q2 and Q3 standings across various categories, including Biochemistry, Genetics and Molecular Biology, Cancer Research, Molecular Medicine, and Physiology. The journal aims to disseminate high-quality research and innovative findings to enhance the understanding of biological processes, making it a vital resource for researchers, professionals, and students alike. With its commitment to open access, FASEB BioAdvances ensures that groundbreaking research is available to a global audience, facilitating collaboration and exploration in these rapidly evolving scientific domains.

Clinical Epidemiology and Global Health, published by Elsevier - Division Reed Elsevier India Pvt Ltd, is a leading open-access journal dedicated to the dissemination of research in the crucial fields of epidemiology and global health. With an ISSN of 2452-0918 and an E-ISSN of 2213-3984, this journal has been a platform for innovative studies since its inception in 2013, converging into a comprehensive resource through 2024. Operating from the Netherlands and ensuring accessibility from anywhere in the world since its transition to an open-access model in 2021, it fosters the global exchange of knowledge. The journal's impact is reflected in its current quartile rankings, including Q2 in Public Health, Environmental and Occupational Health and Q3 in Epidemiology, Infectious Diseases, and Microbiology. With a growing reputation bolstered by SCOPUS rankings that place it in the top percentiles, Clinical Epidemiology and Global Health stands as an essential resource for researchers, professionals, and students dedicated to advancing public health and epidemiological research.

Scientific Chronicles is a distinguished open-access journal published by TZANEIO GENERAL HOSPITAL, specializing in a broad range of scientific disciplines, from biomedical research to environmental sciences. Since its inception in 2014, this journal has dedicated itself to disseminating high-quality research and fostering collaboration within the scientific community. With the ISSN 1791-1362 and E-ISSN 2241-1666, it serves as a vital platform for researchers, professionals, and students to share their findings and innovations. The journal's commitment to accessibility ensures that groundbreaking research reaches a global audience, facilitating knowledge transfer and advancing the frontiers of science. As an open-access publication, Scientific Chronicles aims to bridge the gap between research and practical application, contributing significantly to the continuous advancement of scientific knowledge.

Biomedica is a distinguished journal published by the Instituto Nacional de Salud in Colombia, dedicated to advancing knowledge within the fields of biochemistry, genetics, molecular biology, and general medicine. Since its inception in 1981, this Open Access journal has embodied a commitment to disseminating high-quality research, ensuring free and universal access to its published works. With an impressive Scopus Ranking—273rd out of 636 in Medicine and 148th out of 221 in Biochemistry, Genetics and Molecular Biology—Biomedica holds a Q3 category in both disciplines as of 2023, reflecting its growing impact and relevance in the scientific community. The journal welcomes contributions that further our understanding and lead to advancements in healthcare and biological sciences, serving as a critical resource for researchers, professionals, and students alike. The journal operates within a continuous publication model from 2001 to 2024, enriching the academic landscape with contemporary findings and fostering collaboration within the biomedical field.